Alkermes CEO Pops Calls 2026 a “Really Exciting Year” as Orexin Agonists Near Narcolepsy Launch [Yahoo! Finance]
Alkermes plc - Ordinary Shares (ALKS)
Last alkermes plc - ordinary shares earnings: 4/29 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-irhome
Company Research
Source: Yahoo! Finance
year” that will set the class price and launch trajectory; Alkermes plans to differentiate on patient-centric dosing by launching a range of once-daily doses and split dosing options supported by proprietary PK/efficacy modeling and a split-dose arm added to its IH study. The company cautions against relying only on the MWT , noting its NT2 data showed 70% of patients at the highest dose reporting “normalcy” on ESS, substantial responder heterogeneity, and an early stabilization (not progressive loss) of signal over weeks, which Alkermes will emphasize with more granular data at upcoming meetings. Pops expects an NT1-focused orexin agonist could command orphan pricing ($300k–$400k) while warning of MFN-driven global pricing pressures, and Alkermes is already expanding beyond narcolepsy with a planned large phase II in ADHD this year and programs targeting fatigue (including MS and Parkinson's). Interested in Alkermes plc? Here are five stocks we like better. Alkermes (NASDAQ:A
Show less
Read more
Impact Snapshot
Event Time:
ALKS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALKS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALKS alerts
High impacting Alkermes plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ALKS
News
- Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program [Yahoo! Finance]Yahoo! Finance
- Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ ProgramBusiness Wire
- Alkermes to Present at the Stifel 2026 Virtual CNS Forum [Yahoo! Finance]Yahoo! Finance
- Alkermes to Present at the Stifel 2026 Virtual CNS ForumBusiness Wire
- Alkermes plc Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
ALKS
Earnings
- 2/25/26 - Miss
ALKS
Sec Filings
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- 3/4/26 - Form 4
- ALKS's page on the SEC website